|
Name |
Propylbenzene
|
Molecular Formula | C9H12 | |
IUPAC Name* |
propylbenzene
|
|
SMILES |
CCCC1=CC=CC=C1
|
|
InChI |
InChI=1S/C9H12/c1-2-6-9-7-4-3-5-8-9/h3-5,7-8H,2,6H2,1H3
|
|
InChIKey |
ODLMAHJVESYWTB-UHFFFAOYSA-N
|
|
Synonyms |
Propylbenzene; N-PROPYLBENZENE; 103-65-1; 1-Phenylpropane; Phenylpropane; Benzene, propyl-; Isocumene; 1-Propylbenzene; propyl benzene; Propyl-benzene; Propylbenzene, n-; NSC 16941; 0WR86ZHG2Z; CHEMBL286062; CHEBI:42630; n-Propyl benzene; NSC-16941; Propylbenzene, analytical standard; HSDB 5353; EINECS 203-132-9; UN2364; UNII-0WR86ZHG2Z; Propylbenzene (all isomers); AI3-23862; 3H0; Benzene, n-propyl-; PRPH; Propylbenzene, 98%; BENZENE,PROPYL; PROPYLBENZENE [MI]; DSSTox_CID_22219; DSSTox_RID_79963; PHENYLPROPANE [INCI]; DSSTox_GSID_42219; WLN: 3R; N-PROPYLBENZENE [HSDB]; DTXSID3042219; Propylbenzene, >=99.0% (GC); NSC16941; ZINC1747837; Tox21_300567; BDBM50167945; MFCD00009377; AKOS000120950; ZINC100032913; UN 2364; NCGC00248093-01; NCGC00254532-01; CAS-103-65-1; n-Propylbenzene 100 microg/mL in Methanol; FT-0631559; P0523; S0656; EN300-20607; n-Propyl benzene [UN2364] [Flammable liquid]; A800778; Q288806; J-001016; J-523764; Z104479154
|
|
CAS | 103-65-1 | |
PubChem CID | 7668 | |
ChEMBL ID | CHEMBL286062 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 120.19 | ALogp: | 3.7 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 9 | QED Weighted: | 0.561 |
Caco-2 Permeability: | -4.152 | MDCK Permeability: | 0.00002300 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.922 |
30% Bioavailability (F30%): | 0.68 |
Blood-Brain-Barrier Penetration (BBB): | 0.894 | Plasma Protein Binding (PPB): | 93.40% |
Volume Distribution (VD): | 2.097 | Fu: | 6.01% |
CYP1A2-inhibitor: | 0.972 | CYP1A2-substrate: | 0.825 |
CYP2C19-inhibitor: | 0.869 | CYP2C19-substrate: | 0.398 |
CYP2C9-inhibitor: | 0.407 | CYP2C9-substrate: | 0.408 |
CYP2D6-inhibitor: | 0.111 | CYP2D6-substrate: | 0.28 |
CYP3A4-inhibitor: | 0.034 | CYP3A4-substrate: | 0.294 |
Clearance (CL): | 9.978 | Half-life (T1/2): | 0.618 |
hERG Blockers: | 0.065 | Human Hepatotoxicity (H-HT): | 0.042 |
Drug-inuced Liver Injury (DILI): | 0.045 | AMES Toxicity: | 0.014 |
Rat Oral Acute Toxicity: | 0.057 | Maximum Recommended Daily Dose: | 0.037 |
Skin Sensitization: | 0.517 | Carcinogencity: | 0.373 |
Eye Corrosion: | 0.969 | Eye Irritation: | 0.994 |
Respiratory Toxicity: | 0.108 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000203 | 0.690 | D0P9AC | 0.618 | ||||
ENC000128 | 0.677 | D05OIS | 0.581 | ||||
ENC000779 | 0.622 | D0T3LF | 0.543 | ||||
ENC001728 | 0.611 | D05BMG | 0.543 | ||||
ENC000004 | 0.583 | D0P2GK | 0.525 | ||||
ENC000205 | 0.581 | D0U0RZ | 0.514 | ||||
ENC000014 | 0.581 | D0R0UJ | 0.500 | ||||
ENC000693 | 0.579 | D0P6UB | 0.500 | ||||
ENC000216 | 0.579 | D0G1OZ | 0.475 | ||||
ENC000597 | 0.575 | D0S2UG | 0.444 |